Phase 1 Study of Ceritinib Combined With Trametinib in Patients With Advanced ALK- or ROS1-Positive NSCLCCollin M. Blakely, Bianca Bacaltos, Lea Daran et al.|JTO Clinical and Research Reports|2022Cited by 8